Throughout the 12 months following the initiation of R-CHOP, patients who tended to hyperglycemia were at greater risk of infection, although this was not significant (HR 1.79, 95% CI = 0.76–4.17) (see Figure 4). The gene discussed is DDIT3; the disease is infection.